ES556980A0 - Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina - Google Patents

Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina

Info

Publication number
ES556980A0
ES556980A0 ES556980A ES556980A ES556980A0 ES 556980 A0 ES556980 A0 ES 556980A0 ES 556980 A ES556980 A ES 556980A ES 556980 A ES556980 A ES 556980A ES 556980 A0 ES556980 A0 ES 556980A0
Authority
ES
Spain
Prior art keywords
derivative
benzyl
condensing
addition salt
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556980A
Other languages
English (en)
Other versions
ES8801236A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of ES556980A0 publication Critical patent/ES556980A0/es
Publication of ES8801236A1 publication Critical patent/ES8801236A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES556980A 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina Expired ES8801236A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59064464A JPS60222472A (ja) 1984-03-30 1984-03-30 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物

Publications (2)

Publication Number Publication Date
ES556980A0 true ES556980A0 (es) 1988-01-01
ES8801236A1 ES8801236A1 (es) 1988-01-01

Family

ID=13258978

Family Applications (3)

Application Number Title Priority Date Filing Date
ES541728A Expired ES8702393A1 (es) 1984-03-30 1985-03-29 Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina
ES556981A Expired ES8801237A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
ES556980A Expired ES8801236A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES541728A Expired ES8702393A1 (es) 1984-03-30 1985-03-29 Un procedimiento para preparar un derivado de 1-bencil-4- benzhidril-piperazina
ES556981A Expired ES8801237A1 (es) 1984-03-30 1986-07-29 Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina

Country Status (10)

Country Link
US (1) US4663325A (es)
EP (1) EP0159566B1 (es)
JP (1) JPS60222472A (es)
AT (1) ATE31411T1 (es)
CA (1) CA1248110A (es)
DE (1) DE3561199D1 (es)
ES (3) ES8702393A1 (es)
FI (1) FI79101C (es)
GR (1) GR850787B (es)
NO (1) NO163185C (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
US4792553A (en) * 1986-02-04 1988-12-20 Terumo Kabushiki Kaisha Diene derivatives and vasodilators containing the same
FR2614021B1 (fr) * 1987-04-14 1991-03-01 Andre Buzas Derives de la 1-((1,1-diphenyl)-1-alcenyl)-piperazine, procede d'obtention et compositions pharmaceutiques les contenant
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
AU646926B2 (en) * 1991-03-20 1994-03-10 Duphar International Research B.V. Alkylenedioxyphenyl ether derivatives having anti-ischaemic, memory enhancing and anti-convulsive activity
CA2153979C (en) * 1993-12-08 2003-10-21 Mark Hellberg Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
WO1999038515A1 (en) * 1998-01-29 1999-08-05 Akzo Nobel N.V. Optic papillary circulation improving agents
RU2204556C2 (ru) * 2001-06-18 2003-05-20 Федеральное государственное унитарное предприятие "Новокузнецкий научно-исследовательский химико-фармацевтический институт" Способ получения 1-(парахлорбензгидрил)-4-(2-оксиэтил)пиперазина
CA2495962A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7433519B2 (en) 2003-04-04 2008-10-07 Avid Technology, Inc. Bitstream format for compressed image data
US7403561B2 (en) 2003-04-04 2008-07-22 Avid Technology, Inc. Fixed bit rate, intraframe compression and decompression of video
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
US20060135506A1 (en) * 2003-04-22 2006-06-22 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 hmg―co 억제제로서의 이의 용도
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060205727A1 (en) * 2005-03-11 2006-09-14 Wayne Kaesemeyer Combination therapy for endothelial dysfunction, angina and diabetes
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP1951253A2 (en) 2005-10-26 2008-08-06 Cotherix, Inc. Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
CA2627599A1 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Process for (3r,5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino)carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
US20080153896A1 (en) * 2006-07-14 2008-06-26 Gyan Chand Yadav Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US7964613B2 (en) 2007-02-28 2011-06-21 Asahi Kasei Pharma Corporation Sulfonamide compound
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CN102936233B (zh) * 2012-11-16 2016-01-20 葛长乐 一种1-(二(4-氟苯基)甲基)-4-(2,3,4-三甲氧苯基)哌嗪二盐酸盐晶型
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2017069343A1 (ko) * 2015-10-20 2017-04-27 한국표준과학연구원 위치조절이 용이한 전자현미경용 전자총 및 이를 포함하는 전자현미경
CN109666008A (zh) * 2018-12-31 2019-04-23 辰欣药业股份有限公司 一种盐酸洛美利嗪的合成方法
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB705979A (en) * 1951-03-22 1954-03-24 Henri Morren 1.4-aralkyl piperazines and process for the preparation thereof
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR1303080A (fr) * 1961-07-25 1962-09-07 Science Union Et Compagnie Soc Pipérazines disubstituées
NL7306771A (es) * 1972-06-02 1973-12-04
DE2900810A1 (de) * 1979-01-11 1980-07-24 Cassella Ag Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent

Also Published As

Publication number Publication date
FI79101B (fi) 1989-07-31
GR850787B (es) 1985-11-25
NO163185C (no) 1990-04-18
ES8702393A1 (es) 1987-01-01
EP0159566A1 (en) 1985-10-30
DE3561199D1 (en) 1988-01-28
ES8801236A1 (es) 1988-01-01
NO851298L (no) 1985-10-01
ES541728A0 (es) 1987-01-01
ATE31411T1 (de) 1988-01-15
FI79101C (fi) 1989-11-10
ES556981A0 (es) 1988-01-01
ES8801237A1 (es) 1988-01-01
EP0159566B1 (en) 1987-12-16
CA1248110A (en) 1989-01-03
FI851217A0 (fi) 1985-03-26
JPH0313232B2 (es) 1991-02-22
US4663325A (en) 1987-05-05
FI851217L (fi) 1985-10-01
JPS60222472A (ja) 1985-11-07

Similar Documents

Publication Publication Date Title
ES556981A0 (es) Un procedimiento para preparar un derivado de 1-bencil-4-benzhidrilpiperazina
ES475677A1 (es) Procedimiento para la preparacion de nuevos 4-hidroxi-2h-1,2-benzotiazin-3-carboxamido-1,1-dioxidos.
KR830006228A (ko) 이미다졸 유도체의 제조방법
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
IE820401L (en) N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines
ES515613A0 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
ES508343A0 (es) "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas".
ES504206A0 (es) Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5
DK0453365T3 (da) Fremgangsmåde til fremstilling af 1-(2,3,4-trimethoxybenzyl)piperazin ved reduktiv aminering
ES466851A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-2- imidazolidinilidenbenzamina.
DK154891C (da) Analogifremgangsmaade til fremstilling af thieno-thiazolderivater og deres fysiologisk acceptable syreadditionssalte.
DK154979C (da) Analogifremgangsmaade til fremstilling af phenethanolaminderivater eller farmaceutisk acceptable syreadditionssalte deraf
SE7711146L (sv) Tiaprostaglandiner
ES550781A0 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
ES453787A1 (es) Un procedimiento para la preparacion de compuestos de nido- lina.
ES530073A0 (es) Procedimiento para preparar la n-(3-trifluorometil fenil)-n-propargil-piperazina.
SE8502007D0 (sv) Cyklopentanderivat och sett for framstellning derav
ES537971A0 (es) Procedimiento para la preparacion de derivados indanilicos
JPS5618958A (en) Preparation of n- d-alpha-methyl-beta-mercaptopropionyl -l- proline derivative
CH611283A5 (en) Process for the preparation of arylaminopyrimidine derivatives
IE44951L (en) Pyridoindoles
KR840004438A (ko) 세팔로스포린 유도체의 제조방법
DK128892A (da) Benzyletherderivater
ES457817A3 (es) Un procedimiento para la obtencion de nuevas tieno (2,3-e) (1,4) diacepin-2-onas.
KR920002506A (ko) 벤조페논 유도체의 제조방법

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20071124